Form 4: ASPI CEO Mann Exercises Options, Boosts Stake

ASP Isotopes CEO Paul Mann exercised stock options and sold shares for tax purposes under a 10b5-1 plan, increasing his net beneficial ownership.

Summary

• Paul Elliot Mann, CEO, Director, and 10% Owner of ASP Isotopes Inc. (ASPI), reported multiple transactions involving common stock and employee stock options.
• On September 8, 2025, Mann sold 81,076 shares of common stock at a weighted average price of $8.5279.
• On September 9, 2025, Mann exercised employee stock options to acquire 216,000 shares of common stock at an exercise price of $2.00 per share.
• Also on September 9, 2025, Mann exercised employee stock options to acquire 1,000,000 shares of common stock at an exercise price of $2.00 per share.
• To cover tax withholding obligations related to restricted stock awards, Mann sold an additional 81,077 shares of common stock at a weighted average price of $8.3886 on September 9, 2025, under a Rule 10b5-1 trading plan.
• Additionally, 50,644 shares and 234,466 shares were withheld by the company at $8.53 per share to satisfy the exercise price associated with the option exercises.
• Following these transactions, Mann's direct beneficial ownership of common stock increased to 8,084,191 shares, representing a net increase of 768,737 shares from the initial reported beneficial ownership in this series of transactions.

Sentiment

Score: 7

Explanation: The sentiment is moderately positive. While there were sales, they were pre-planned for tax purposes. The significant exercise of options at a low price, coupled with a net increase in the CEO's beneficial ownership, indicates continued confidence in the company's value.

Positives

• CEO Paul Mann increased his direct beneficial ownership of ASP Isotopes Inc. common stock by a net of 768,737 shares through these transactions, demonstrating continued commitment and confidence in the company.
• The exercise of 1,216,000 employee stock options at a low exercise price of $2.00, significantly below the market prices at which shares were sold or withheld (ranging from $8.135 to $8.575), indicates a substantial unrealized gain being realized by the executive.
• The transactions were conducted under a Rule 10b5-1 trading plan, indicating pre-planned activity and reducing concerns about opportunistic insider trading.

Negatives

• While a net increase in shares occurred, a total of 162,153 shares were sold on the open market to cover tax withholding obligations, and an additional 285,110 shares were withheld by the company to satisfy option exercise prices. These actions represent a reduction in the gross number of shares that could have been held by the CEO.

Future Outlook

NA

Management Comments

• The sales of common stock were effected pursuant to a Rule 10b5-1 trading plan adopted on June 9, 2025, to cover tax withholding obligations in connection with the vesting of restricted stock awards.
• Shares were withheld by the Company in connection with net share settlement to satisfy the exercise price associated with the reporting person's exercise of employee stock options; no shares were sold by the reporting person to satisfy the exercise price or any tax liability.

Industry Context

NA

Corporate Governance

Stakeholder Impact

• Shareholders gain insight into insider activity, specifically a net increase in the CEO's holdings, which can be seen as a positive signal of confidence in the company's future prospects.
• Regulatory authorities are informed of the executive's transactions, demonstrating compliance with Section 16(a) of the Securities Exchange Act of 1934 and the use of a Rule 10b5-1 plan for managing equity sales.

Key Dates

Recommendation

The reported transactions are routine insider activities, primarily involving the exercise of stock options and subsequent sales to cover tax obligations under a pre-arranged 10b5-1 plan. While there's a net increase in the CEO's beneficial ownership, these actions do not signal a material change in the company's fundamental outlook or strategic direction that would warrant a 'buy' or 'sell' recommendation. Investors should 'hold' and monitor broader company performance and market trends.

Keywords

ASPI, ASP Isotopes Inc., Paul Mann, CEO, Insider Trading, Form 4, Stock Options, Equity Compensation, Rule 10b5-1 Plan